Profil
Robert Guglielmetti currently works at Antoax A, as Chief Executive Officer, Pharmacosmos Holding A, as Chief Financial Officer & Director from 2010, and Pharmacosmos A, as Chief Financial Officer & Executive Vice President.
Aktive Positionen von Robert Guglielmetti
| Unternehmen | Position | Beginn |
|---|---|---|
Pharmacosmos A/S
 Pharmacosmos A/S Pharmaceuticals: MajorHealth Technology Pharmacosmos A/S develops treatments of iron deficiency anemia in humans and animals. Its products include monofer, cosmofer, diafer and uniferon. The company was founded by Dr. Henry M. Christensen in 1965 and is headquartered in Holbæk, Denmark. | Finanzdirektor/CFO | 14.02.2011 |
Pharmacosmos Holding A/S
 Pharmacosmos Holding A/S Pharmaceuticals: MajorHealth Technology Pharmacosmos Holding A/S conducts business with the development of pharmaceutical, chemical, and technical products and processes. It also acquires, owns, and administers rights in connection therewith; and to own shares in companies engage in the development, production, and trade of pharmaceutical, chemical, and technical products. The company was founded on October 12, 1965 and is headquartered in Holbaek, Denmark. | Finanzdirektor/CFO | 14.06.2010 |
Antoax A/S
 Antoax A/S Financial ConglomeratesFinance Antoax A/S is an investment holding Danish company. The company is based in Holbæk, DK and has subsidiaries in the United States, Denmark, and the United Kingdom. The company was founded in 2004. The CEO is Robert Guglielmetti. | Vorstandsvorsitzender | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Antoax A/S
Antoax A/S Financial ConglomeratesFinance Antoax A/S is an investment holding Danish company. The company is based in Holbæk, DK and has subsidiaries in the United States, Denmark, and the United Kingdom. The company was founded in 2004. The CEO is Robert Guglielmetti. | Finance |
Pharmacosmos Holding A/S
Pharmacosmos Holding A/S Pharmaceuticals: MajorHealth Technology Pharmacosmos Holding A/S conducts business with the development of pharmaceutical, chemical, and technical products and processes. It also acquires, owns, and administers rights in connection therewith; and to own shares in companies engage in the development, production, and trade of pharmaceutical, chemical, and technical products. The company was founded on October 12, 1965 and is headquartered in Holbaek, Denmark. | Health Technology |
Pharmacosmos A/S
Pharmacosmos A/S Pharmaceuticals: MajorHealth Technology Pharmacosmos A/S develops treatments of iron deficiency anemia in humans and animals. Its products include monofer, cosmofer, diafer and uniferon. The company was founded by Dr. Henry M. Christensen in 1965 and is headquartered in Holbæk, Denmark. | Health Technology |